FDA Approval of Medical Marijuana - Studies Explored by Experts

Author: United Cannabis Corporation - Contact: www.unitedcannabis.us
Published: 2014/06/04
Topic: Medical Marijuana and Cannabis - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Experts to explore safety data required for Institutional Review Board and FDA approval of human Phase I, II, III studies on use of medicinal marijuana.

Introduction

Recent appointees to a team of experts will explore the safety data required for Institutional Review Board (IRB) and FDA approval of human (Phase I, II, III) studies on the use of medicinal marijuana.

Focus

Brent A. Reynolds PhD, and Dennis A. Steindler PhD will focus on the Federal requirements necessary for approval to market medicinal marijuana drugs in legal communities.

As newly appointed Directors, Drs. Reynolds and Steindler will run and manage the Discovery Research & Development division of United Cannabis Corporation.

The Doctors will establish evidence of cannabis-based medical efficacy, and create Intellectual Property (IP) on medically efficient cannabinoid-based products.

Exploring the medical applications of cannabinoids, the Doctors will focus on IP claims, protecting products and their application, pre-clinical exploratory, proof of principal, and the safety data required for Institutional Review Board (IRB) and FDA approval of human (Phase I, II, III) studies on the use of medicinal marijuana.

"Based on the evidence and efficacy of our programs, we are building a foundation established on human studies. United Cannabis will seek out the science behind full spectrum cannabinoids to develop synergistic medicine that compliments conventional therapies.

The Company now has an opportunity that not only allows us to research the plant, but with the recently appointed expert team of Drs. Reynolds and Steindler, we can convert those findings into realized products FDA approved for medical applications," notes Tony Verzura, VP United Cannabis Corporation.

Explore Similar Topics

: What legal Cannabis in Canada means for Science showcases research demonstrating how industry developments are expected to promote growth over 50%.

: Medical cannabis patients and businesses are protected from federal intervention after President Trump signed the new spending bill into law.

Citing and References

Founded in 2004, Disabled World (DW) is a leading resource on disabilities, assistive technologies, and accessibility, supporting the disability community. Learn more on our About Us page.

Cite This Page: United Cannabis Corporation. (2014, June 4). FDA Approval of Medical Marijuana - Studies Explored by Experts. Disabled World (DW). Retrieved May 24, 2025 from www.disabled-world.com/medical/pharmaceutical/marijuana/phase-1.php

Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/marijuana/phase-1.php">FDA Approval of Medical Marijuana - Studies Explored by Experts</a>: Experts to explore safety data required for Institutional Review Board and FDA approval of human Phase I, II, III studies on use of medicinal marijuana.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.